HC Wainwright & Co. Maintains Buy on Rezolute, Raises Price Target to $10

9/25/2026
Impact: 70
Healthcare

HC Wainwright & Co. analyst Douglas Tsao has maintained a Buy rating on Rezolute (NASDAQ: RZLT) and increased the price target from $5 to $10. This adjustment reflects a positive outlook for the company's performance.

AI summary, not financial advice

Share: